Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.
Market Data
Essential tool: analyze, trade, manage, decide.
What’s Your Call?
Collective community sentiment on Trident Lifeline Ltd
Your Vote -
Buy
25.00%
Hold
50.00%
Sell
25.00%
25.00%
4 users have voted
Option Chain
Analyzes market sentiment, predicts Trident Lifeline Ltd' movement.
NO_RECORD_FOUND
News
Media spotlight triggers stock stock attention, sentiment.
-
Trident Lifeline - Announcement Under Regulation 30- Cessation Of Corporate Office
-
Trident Lifeline - Intimation Under Regulation 30 Of SEBI (LODR) Regulations, 2015 -Launch Of New Skin Care Brand 'YES' By Su
-
Trident Lifeline - Scrutinizer\S Report
-
Trident Lifeline - Shareholder Meeting / Postal Ballot-Outcome of EGM
-
Trident Lifeline Q4 net profit jumps 47.76% at Rs 3.62 cr
-
Trident Lifeline - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
-
Trident Lifeline - Non-Applicability Of Regulation 23(9) Of SEBI (Listing Obligation & Disclosures Requirements) Regulation,
-
Trident Lifeline - Integrated Filing (Financial)
-
Trident Lifeline - Statement Of Deviation Or Variation Of Funds Under Regulation 32 Of SEBI (Listing Obligations And Disclosu
-
Trident Lifeline - Appointment Of Internal Auditor
-
Trident Lifeline - Result-Financial Result For The Half Year And Year Ended On March 31, 2025
-
Trident Lifeline - Board Meeting Outcome for Outcome Of Board Meeting Held On 28 April, 2025
-
Trident Lifeline - Board Meeting Intimation for Approval Of Audited Standalone And Consolidated Financial Results For The Hal
-
Trident Lifeline has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2025
-
Trident Lifeline - Shareholder's Meeting-EGM-09-05-2025
-
Trident Lifeline - Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requiremen
-
Trident Lifeline - Announcement under Regulation 30 (LODR)-Issue of Securities
-
Trident Lifeline - Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association
-
Trident Lifeline - Board Meeting Outcome for Outcome Of Board Meeting Held On Today I.E. 16.04.2025
-
Trident Lifeline - Shareholder's Meeting-EGM-09-05-2025
-
Trident Lifeline - Shareholder's Meeting-EGM-09-05-2025
-
Trident Lifeline - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
-
Trident Lifeline - Board Meeting Intimation for Consider And Approve The Proposal To Raise Funds At The Board Meeting To Be H
-
Trident Lifeline - Disclosure Under Regulation 30 Of LODR- Cessation Of Step-Down Subsidiary Company
-
Trident Lifeline - Board Meeting Outcome for Outcome Of Separate Meeting Of Independent Directors
-
Trident Lifeline - Disclosure As Per Regulation 7(2) Of SEBI (Prohibition Of Insider Trading) Regulations, 2015
-
Trident Lifeline - Disclosure Under Regulation 29(1) Of SEBI (Substantial Acquisition Of Shares And Takeover) Regulations, 20
-
Trident Lifeline - Intimation Pursuant To Regulation 30 - Corporate Guarantee
-
Trident Lifeline - Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements
-
Trident Lifeline - Disclosure As Per Regulation 7(2) Of SEBI (Prohibition Of Insider Trading) Regulations, 2015
-
Trident Lifeline - Disclosure Under Regulation 29(1) Of SEBI (Substantial Acquisition Of Shares And Takeover) Regulations, 20
-
Trident Lifeline - Disclosure As Per Regulation 7(2) Of SEBI (Prohibition Of Insider Trading) Regulations, 2015
-
Trident Lifeline - Disclosure Under Regulation 29(2) Of SEBI (Substantial Acquisition Of Shares And Takeover) Regulations, 20
-
Trident Lifeline - Intimation Pursuant To Regulation 30 - Corporate Guarantee
Key fundamentals
Evaluate the intrinsic value of Trident Lifeline Ltd stock
| Name | March-25 | March-24 | March-23 | March-22 | March-21 |
|---|---|---|---|---|---|
| Assets | 80.6215 | 58.8707 | 49.0094 | 7.2556 | 4.0546 |
| Liabilities | 80.6215 | 58.8707 | 49.0094 | 7.2556 | 4.0546 |
| Equity | 11.4992 | 11.4992 | 11.4992 | 8 | 5 |
| Gross Profit | 17.522 | 8.8297 | 6.2509 | 2.7613 | 1.2432 |
| Net Profit | 13.0514 | 7.0434 | 6.012 | 2.2732 | 0.6323 |
| Cash From Operating Activities | -3.4931 | 0.8953 | -16.6037 | -0.2521 | 1.4846 |
| NPM(%) | 19.25 | 15.77 | 18.96 | 10.44 | 6.57 |
| Revenue | 67.7991 | 44.6524 | 31.6922 | 21.7679 | 9.6223 |
| Expenses | 50.2771 | 35.8227 | 25.4413 | 19.0066 | 8.3791 |
| ROE(%) | 22.67 | 12.23 | 10.44 | 3.94 | 1.09 |
Corporate Action
| XD-Date | Dividend-Amount | Dividend-% | Dividend Yield(%GE) | Price on that day |
|---|
Peers
Other companies within the same industry or sector that are comparable to Trident Lifeline Ltd
| Company | Price | Price (% change) | pe(x) | EV/EBITDA(x) | ROE(%) | ROCE(%) |
|---|---|---|---|---|---|---|
| Albert David Ltd | 810.05 | -1.12 | 26.88 | 166.68 | 301.39 | 0.62 |
| Lotus Eye Hospital and Institute Ltd | 74.39 | 0.39 | 308.58 | 607.36 | 14.01 | 0.68 |
| Bharat Immunological and Biologicals Corporation Ltd | 25.66 | -5.45 | 0.00 | 1261.07 | -39.50 | 0.00 |
| Astec Lifesciences Ltd | 698.00 | -1.87 | 0.00 | 572.68 | -687.11 | 0.00 |
Company Info
Our Company was originally incorporated as "Trident Lifeline Private Limited" as a Private Limited Company under the provisions of the Companies Act, 1956 vide Certificate of Incorporation dated January 09, 2014, issued by the Registrar of Companies, Gujarat, Dadra and Nagar Havelli. Subsequently, our Company was converted into a Public Limited Company pursuant to shareholders resolution passed at Extra-ordinary General Meeting of our Company held on June 02, 2022 and the name of our Company was changed to "Trident Lifeline Limited". A fresh Certificate of Incorporation consequent upon Conversion from Private Limited Company to Public Limited Company dated June 10, 2022 was issued by the Registrar of Companies, Ahmedabad. The Corporate Identification Number of our Company is U51909GJ2014PLC078227.Our promoters and directors have a combined experience of more than 19 years in the pharmaceutical products, Bulk drugs. Driven by the passion for building an integrated pharmaceutical company, backed by their experience, our Promoters have been the pillars of our Company's growth and have built a strong value system for our Company. With their enriching experience and progressive thinking, we aim to continue to grow in the pharmaceutical and bulk drugs industry.Our Company is engaged in the pharmaceutical business ethical marketing in domestic as well as inernational market. We are also engaged in distribution of pharmaceutical products through third party distribution network. We offer wide range of pharmaceutical formulations and products manufactured on contract manufacturing under loan lisence. We operate in India as well as African, Latin American and East Indian Countries. We have our presence through registered products or products under registration in countries like Bolivia, Cambodia, Cameroon, Chile, Ghana, Kenya, Myanamar, Nigeria, Peru, Sudan, Tajikistan, Uzbekistan, Venuzela.We deal in Capsules, Tablets, Liquid Ointment, Gel, Ice Gel, Mouthwash, Paste, Solution, Suspension, Drypowders and Toothpaste. Our product portfolio comprises of vide range of drugs like Anti Bacterial, Anti Diarrheal, Anti Fungal, Anti Malerial, Anti Diabetic, Dental Cure, Proton Pump Inhibitor, Anti Protozol, Anti Histamine, Anti Hypertensive drugs, Anti Lipidemic Drug, Anti Parasitic, Multivitamin, Multimineral Nyteraceutical and Non-steriodal anti-inflamatory drug (NSAIDS). Our product portfolio consists of 832 products, as on May 31, 2022. We operate under different brand names across the globe. As on May 31, 2022, we have 267 products registered in total 8 countries. As on May 31, 2022, total565 products are under process of registration in 11 countries, which shall boost the growth of our company.MAJOR EVENTS2014Our Company was incorporated as a private limited company under the name "Trident Lifeline Private Limited" Limited2021Our Company had Certified its Quality Management System Under the Certificate ISO 9001:2015. 2021 -Exports to LATAM and CIS Countries. 2022 -Acquisition of TNS Pharma Pvt. Ltd. 2024 -Acquisition of TLL Herbal Ltd. -Acquisition of 18% equity in Tricorp
Our Company was originally incorporated as "Trident Lifeline Private Limited" as a Private Limited Company under the provisions of the Companies Act, 1956 vide Certificate of Incorporation dated January 09, 2014, issued by the Registrar of Companies, Gujarat, Dadra and Nagar Havelli. Subsequently, our Company was converted into a Public Limited Company pursuant to shareholders resolution passed at Extra-ordinary General Meeting of our Company held on June 02, 2022 and the name of our Company was changed to "Trident Lifeline Limited". A fresh Certificate of Incorporation consequent upon Conversion from Private Limited Company to Public Limited Company dated June 10, 2022 was issued by the Registrar of Companies, Ahmedabad. The Corporate Identification Number of our Company is U51909GJ2014PLC078227.Our promoters and directors have a combined experience of more than 19 years in the pharmaceutical products, Bulk drugs. Driven by the passion for building an integrated pharmaceutical company, backed by their experience, our Promoters have been the pillars of our Company's growth and have built a strong value system for our Company. With their enriching experience and progressive thinking, we aim to continue to grow in the pharmaceutical and bulk drugs industry.Our Company is engaged in the pharmaceutical business ethical marketing in domestic as well as inernational market. We are also engaged in distribution of pharmaceutical products through third party distribution network. We offer wide range of pharmaceutical formulations and products manufactured on contract manufacturing under loan lisence. We operate in India as well as African, Latin American and East Indian Countries. We have our presence through registered products or products under registration in countries like Bolivia, Cambodia, Cameroon, Chile, Ghana, Kenya, Myanamar, Nigeria, Peru, Sudan, Tajikistan, Uzbekistan, Venuzela.We deal in Capsules, Tablets, Liquid Ointment, Gel, Ice Gel, Mouthwash, Paste, Solution, Suspension, Drypowders and Toothpaste. Our product portfolio comprises of vide range of drugs like Anti Bacterial, Anti Diarrheal, Anti Fungal, Anti Malerial, Anti Diabetic, Dental Cure, Proton Pump Inhibitor, Anti Protozol, Anti Histamine, Anti Hypertensive drugs, Anti Lipidemic Drug, Anti Parasitic, Multivitamin, Multimineral Nyteraceutical and Non-steriodal anti-inflamatory drug (NSAIDS). Our product portfolio consists of 832 products, as on May 31, 2022. We operate under different brand names across the globe. As on May 31, 2022, we have 267 products registered in total 8 countries. As on May 31, 2022, total565 products are under process of registration in 11 countries, which shall boost the growth of our company.MAJOR EVENTS2014Our Company was incorporated as a private limited company under the name "Trident Lifeline Private Limited" Limited2021Our Company had Certified its Quality Management System Under the Certificate ISO 9001:2015. 2021 -Exports to LATAM and CIS Countries. 2022 -Acquisition of TNS Pharma Pvt. Ltd. 2024 -Acquisition of TLL Herbal Ltd. -Acquisition of 18% equity in Tricorp
Read More
Parent Organisation
Trident Lifeline Ltd.
Founded
09/01/2014
Managing Director
Mr.Shravan Harikrishna Patel
NSE Symbol
FAQ
The current price of Trident Lifeline Ltd is
The 52-week high for Trident Lifeline Ltd is
The market capitalization of Trident Lifeline Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.
To buy Trident Lifeline Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.
To invest in Trident Lifeline Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Trident Lifeline Ltd shares.
The CEO of Trident Lifeline Ltd is Mr.Shravan Harikrishna Patel, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.
